"Theranostic Nanomedicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An integrated nano-scale approach to MEDICINE which involves concurrent diagnosis, drug delivery, therapy, and monitoring of therapeutic response.
| Descriptor ID |
D000068936
|
| MeSH Number(s) |
E01.894 E02.921 H01.603.600.500 H02.403.845 J01.897.520.600.600.500
|
| Concept/Terms |
Theranostic Nanomedicine- Theranostic Nanomedicine
- Nanomedicine, Theranostic
- Nanomedicines, Theranostic
- Theranostic Nanomedicines
|
Below are MeSH descriptors whose meaning is more general than "Theranostic Nanomedicine".
Below are MeSH descriptors whose meaning is more specific than "Theranostic Nanomedicine".
This graph shows the total number of publications written about "Theranostic Nanomedicine" by people in this website by year, and whether "Theranostic Nanomedicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Theranostic Nanomedicine" by people in Profiles.
-
Re/99mTc Tricarbonyl Phenformin Complexes Targeting Mitochondria as Pancreatic Cancer Theranostics. J Med Chem. 2025 Nov 13; 68(21):22818-22830.
-
Nanotechnology synergized immunoengineering for cancer. Eur J Pharm Biopharm. 2021 Jun; 163:72-101.
-
Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy. Adv Healthc Mater. 2021 03; 10(5):e2001044.
-
Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near-infrared light mediated cancer therapy. Commun Biol. 2020 06 05; 3(1):284.
-
Bypassing pro-survival and resistance mechanisms of autophagy in EGFR-positive lung cancer cells by targeted delivery of 5FU using theranostic Ag2S quantum dots. J Mater Chem B. 2019 12 14; 7(46):7363-7376.
-
Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release. ACS Nano. 2017 07 25; 11(7):7259-7273.
-
Crossing the barrier: treatment of brain tumors using nanochain particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 09; 8(5):678-95.
-
X-ray Radiation-Controlled NO-Release for On-Demand Depth-Independent Hypoxic Radiosensitization. Angew Chem Int Ed Engl. 2015 Nov 16; 54(47):14026-30.